Sharps Technology, Inc.

NasdaqCM:STSS Stock Report

Market Cap: US$4.5m

Sharps Technology Past Earnings Performance

Past criteria checks 0/6

Sharps Technology's earnings have been declining at an average annual rate of -32.2%, while the Medical Equipment industry saw earnings growing at 13.4% annually.

Key information

-32.2%

Earnings growth rate

-2.3%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth raten/a
Return on equity-124.0%
Net Marginn/a
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Sharps Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:STSS Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-1092
30 Sep 230-882
30 Jun 230-882
31 Mar 230-582
31 Dec 220-562
30 Sep 220-552
30 Jun 220-452
31 Mar 220-632
31 Dec 210-532
30 Sep 210-421
31 Dec 200-221

Quality Earnings: STSS is currently unprofitable.

Growing Profit Margin: STSS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: STSS is unprofitable, and losses have increased over the past 5 years at a rate of 32.2% per year.

Accelerating Growth: Unable to compare STSS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: STSS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Return on Equity

High ROE: STSS has a negative Return on Equity (-124.04%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.